Company profile
AbCellera Biologics Inc.
NASDAQ:ABCLBiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07108894 | phase1 | active_not_recruiting | 2025-07-25 | 2027-04-01 | AbCellera Biologics Inc. | A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants |
| NCT07118891 | phase1_2 | active_not_recruiting | 2025-06-23 | 2027-02-01 | AbCellera Biologics Inc. | Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause |
FDA applications (0)
No records yet.